Litigation Details for BAYER PHARMA AG v. WATSON LABORATORIES, INC. (D.N.J. 2014)
✉ Email this page to a colleague
BAYER PHARMA AG v. WATSON LABORATORIES, INC. (D.N.J. 2014)
Docket | ⤷ Sign Up | Date Filed | 2014-03-21 |
Court | District Court, D. New Jersey | Date Terminated | 2014-06-02 |
Cause | 35:271 Patent Infringement | Assigned To | Jose L. Linares |
Jury Demand | Referred To | Joseph A. Dickson | |
Patents | 6,362,178; 7,696,206 | ||
Link to Docket | External link to docket |
Small Molecule Drugs cited in BAYER PHARMA AG v. WATSON LABORATORIES, INC.
Details for BAYER PHARMA AG v. WATSON LABORATORIES, INC. (D.N.J. 2014)
Date Filed | Document No. | Description | Snippet | Link To Document |
---|---|---|---|---|
2014-06-02 | 28 | subsequently obtained U.S. Patent No. 6,362,178 on March 2002, ('178 Patent, Decl. of Thomas S. Fletcher…'178 Patent and e '206 Patent are referred to as the "Compound Patents"). …ECF No. 20-3), and U.S. Patent 7,696,206 on April13, 2010, ('206 Patent, Decl. of Thomas S. Fletcher…. . for a drug claimed in a patent or the use of whic claimed in a patent." …issues related to b th the Compound Patents and the Formulation Patent could be addressed in a single proceedi | External link to document | |
>Date Filed | >Document No. | >Description | >Snippet | >Link To Document |